
MoldCo is a healthcare company focused on addressing the health impacts of mold exposure. It provides a comprehensive approach to treating mold toxicity, including specialized biomarker testing, research-supported treatments like binders and peptides, and nasal biofilm disruptors. These solutions are guided by mold-trained clinicians and are available entirely online. MoldCo has developed evidence-based methods to restore metabolic health, clear harmful microbes, and reduce inflammation. The company has treated over 30,000 patients and aims to address the often-overlooked health crisis caused by mold exposure.